Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
8th Jan 20209:52 amRNSHolding(s) in Company
3rd Jan 20208:01 amRNSTotal Voting Rights
3rd Jan 20207:57 amRNSNet Asset Value(s)
20th Dec 20193:14 pmRNSNet Asset Value(s)
16th Dec 201912:09 pmRNSNet Asset Value(s)
10th Dec 20192:54 pmRNSTransaction in Own Shares
10th Dec 201912:16 pmRNSDirector/PDMR Shareholding
10th Dec 201912:08 pmRNSIssue of Equity
9th Dec 201910:06 amRNSNet Asset Value(s)
2nd Dec 20194:44 pmRNSNet Asset Value(s)
2nd Dec 20192:44 pmRNSTransaction in Own Shares
2nd Dec 201910:13 amRNSTotal Voting Rights
26th Nov 20192:43 pmRNSDirector/PDMR Shareholding
26th Nov 201912:39 pmRNSIssue of Equity
25th Nov 20192:34 pmRNSTransaction in Own Shares
22nd Nov 20195:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20194:05 pmRNSIssue of Equity
22nd Nov 20191:40 pmRNSNet Asset Value(s)
22nd Nov 20197:00 amRNSHolding(s) in Company
18th Nov 20193:51 pmRNSTransaction in Own Shares
18th Nov 201911:53 amRNSNet Asset Value(s)
8th Nov 20195:24 pmRNSNet Asset Value(s)
4th Nov 201911:54 amRNSNet Asset Value(s)
1st Nov 20199:34 amRNSTotal Voting Rights
31st Oct 20195:02 pmRNSOffer for subscription
28th Oct 201912:25 pmRNSTransaction in Own Shares
28th Oct 201911:50 amRNSNet Asset Value(s)
18th Oct 20194:16 pmRNSNet Asset Value(s)
16th Oct 201911:29 amRNSTransaction in Own Shares
16th Oct 201910:23 amRNSNet Asset Value(s)
8th Oct 20192:07 pmRNSHalf-year Report
8th Oct 20191:33 pmRNSDividend Declaration
7th Oct 201910:09 amRNSNet Asset Value(s)
1st Oct 20195:20 pmRNSNet Asset Value(s)
1st Oct 20199:20 amRNSTotal Voting Rights
25th Sep 20192:41 pmRNSTransaction in Own Shares
20th Sep 20194:41 pmRNSNet Asset Value(s)
17th Sep 201910:22 amRNSTransaction in Own Shares
16th Sep 20193:25 pmRNSNet Asset Value(s)
10th Sep 20191:08 pmRNSTransaction in Own Shares
6th Sep 20195:34 pmRNSNet Asset Value(s)
2nd Sep 20195:18 pmRNSNet Asset Value(s)
2nd Sep 20198:05 amRNSTotal Voting Rights
30th Aug 20196:17 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSUpdate on offer for subscription
27th Aug 20192:27 pmRNSNet Asset Value(s)
23rd Aug 20191:41 pmRNSTransaction in Own Shares
20th Aug 20192:33 pmRNSTransaction in Own Shares
19th Aug 20192:06 pmRNSNet Asset Value(s)
15th Aug 20195:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.